Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-19 of 19 (Search time: 0.015 seconds).
Item hits:
Issue DateTitleAuthor(s)
2-Nov-2014Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with LPV/r+3TC for initial ART in HIV infected adults.Gatell, José M.; Arribas, José Ramón; Lázaro, Pablo; Blasco, Antonio
29-Jul-1993Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeterCooper, David A.; Gatell, José M.; Kroon, Susanne; Clumeck, Nathan; Millard, Judith; Goebel, Frank-D; Bruun, Johan N.; Stingl, Georg; Melville, Rex L.; González Lahoz, Juan María; Stevens, John W.; Fiddian, A. Paul; Gudiol i Munté, Francesc; Miró Meda, José M.; Mallolas Masferrer, Josep; European-Australian Collaborative Group
25-Mar-2014Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D studyKamara, David A.; Ryom, Lene; Ross, Michael; Kirk, Ole; Reiss, Peter; Morlat, Philippe; Moranne, Olivier; Fux, Christoph; Mocroft, Amanda; Sabin, Caroline; Lundgren, Jens D.; Smith, Colette J.; Miró Meda, José M.; Gatell, José M.
4-Oct-2011Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adultsFerrer, Elena; Río, Luis del; Martínez Chamorro, Esteban José; Curto, J. J. (Jorge Juan); Domingo, Pere (Domingo Pedrol); Ribera, Esteban; Negredo, Eugènia; Rosales, Joaquín; Saumoy, Maria; Ordóñez, J. (Jordi), 1952-; Gatell, José M.; Podzamczer Palter, Daniel
2014Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressorsEgaña Gorroño, Lander; Escribà, Tuixent; Boulanger, Nicolas; Crespo Guardo, Alberto; León García, Agathe; Bargalló, Manel Enric; García, Felipe; Gatell, José M.; Plana Prades, Montserrat; Arnedo, Mireia
28-May-2014Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulationNordell, Anna D.; McKenna, Matthew; Borges, Álvaro H.; Duprez, Daniel; Neuhaus, Jacqueline; Neaton, James D.; Gatell, José M.
2014Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patientsGatell, José M.; Morales Ramirez, Javier O.; Hagins, Debbie P.; Thompson, Melanie; Keikawus, Arasteh; Hoffmann, Christian; Rugina, Sorin; Osiyemi, Olayemi; Escoriu, Simona; Dretler, Robin; Harvey, Charlotte; Xu, Xia; Teppler, Hedy
15-Jan-2013Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)Sullivan, Ann K.; Raben, Dorthe; Reekie, Joanne; Rayment, Michael; Mocroft, Amanda; Esser, Stefan; León García, Agathe; Begovac, Josip; Brinkman, Kees; Zangerle, Robert; Grzeszczuk, Anna; Vassilenko, Anna; Hadziosmanovic, Vesna; Krasnov, Maksym; Sönnerborg, Anders; Clumeck, Nathan; Gatell, José M.; Gazzard, Brian; Arminio Monforte, Antonella d'; Rockstroh, Jürgen Kurt; Lundgren, Jens D.
31-Aug-2012Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV InfectionHamlyn, Elizabeth; Ewings, Fiona M.; Porter, Kholoud; Cooper, David A.; Tambussi, Giuseppe; Schechter, Mauro; Pedersen, Court; Okulicz, Jason F.; McClure, Myra; Babiker, Abdel; Weber, Jonathan; Fidler, Sarah; Miró Meda, José M.; López-Diéguez, María; Manzardo, Christian; Arnaiz Gargallo, Juan Alberto; Pumarola Suñé, Tomàs; Plana Prades, Montserrat; Tuset Creus, Montserrat; Ligero, M. C.; García, M. T.; Gallart, Teresa; Gatell, José M.; INSIGHT SMART; SPARTAC Trial Investigators